Showing results (561-570 of 607) with videos related to
Sort By:
Pageof 61
Plos One|December 2, 2011
Multiple cytokines are released when blood from patients with tuberculosis is stimulated with Mycobacterium tuberculosis antigensKathryn L Kellar, Jennifer Gehrke, Stephen E Weis, et al.Royal Society Open Science|November 18, 2022
Demography of an ice-obligate mysticete in a region of rapid environmental changeL Pallin, K C Bierlich, J Durban, et al.Plos One|January 6, 2017
The Effectiveness of Pharmacological and Non-Pharmacological Interventions for Improving Glycaemic Control in Adults with Severe Mental Illness: A Systematic Review and Meta-AnalysisJohanna Taylor, Brendon Stubbs, Catherine Hewitt, et al.Plos One|October 26, 2021
Exploring the facilitators, barriers, and strategies for self-management in adults living with severe mental illness, with and without long-term conditions: A qualitative evidence synthesisAbisola Balogun-Katung, Claire Carswell, Jennifer V E Brown, et al.Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|January 8, 2026
Mixed methods process evaluation of behavioural support and nicotine replacement therapy for smokeless tobacco cessation in Bangladesh, India, and PakistanFaraz Siddiqui, Fayaz Ahmad, Fariza Fieroze, et al.Research in Social & Administrative Pharmacy : RSAP|November 30, 2025
The feasibility of implementing a hospital deprescribing behaviour change intervention and undertaking trial processes: A mixed methods evaluationSion Scott, Jacqueline Martin-Kerry, Megan Pritchard, et al.BMJ Open|June 18, 2024
Cognitive therapy for depression in tuberculosis treatment: protocol for multicentre pragmatic parallel arm randomised control trial with an internal pilotNishani Fonseka, Zohaib Khan, Martyn Lewis, et al.Journal of Medicinal Chemistry|September 20, 2013
Design, synthesis and discovery of picomolar selective α4β2 nicotinic acetylcholine receptor ligandsVenkata M Yenugonda, Yingxian Xiao, Edward D Levin, et al.Journal of Biomolecular Screening|October 5, 2014
Lead identification to clinical candidate selection: drugs for Chagas diseaseR Jeffrey Neitz, Steven Chen, Frantisek Supek, et al.Journal of Medicinal Chemistry|October 3, 2015
Scaffold-Hopping and Structure-Based Discovery of Potent, Selective, And Brain Penetrant N-(1H-Pyrazol-3-yl)pyridin-2-amine Inhibitors of Dual Leucine Zipper Kinase (DLK, MAP3K12)Snahel Patel, Seth F Harris, Paul Gibbons, et al.Pageof 61